Core Growth and Adjusted EBITDA Margin
Fourth quarter core growth of 2% and an adjusted EBITDA margin of 13.9%, consistent with expectations.
Implants Business Improvement
Continued improvement in the implants business, including positive growth in North America.
Spark Performance
Spark grew double-digits in 2024, with consecutive quarter-on-quarter gross margin improvement and plans to turn operating profit positive in the second half of 2025.
Free Cash Flow Increase
$303 million in free cash flow for 2024, up 35% compared to the prior year.
Share Repurchase Program
Board authorized share repurchases of up to $250 million over the next two years.
Operational Improvements
Strong contributions from the Envista Business System, with improvements in working capital and customer service.
Leadership and Talent Development
Refreshed senior team with world-class leaders and made investments in engagement and talent development.